Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Sharon, Leclercq"'
Autor:
Deborah A. Marshall, Tram Pham, Peter Faris, Guanmin Chen, Siobhan O’Donnell, Claire E. H. Barber, Sharon LeClercq, Steven Katz, Joanne Homik, Jatin N. Patel, Elena Lopatina, Jill Roberts, Dianne Mosher
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 7, Pp 424-429 (2020)
Objective The objective of the study was to estimate the incidence and prevalence of rheumatoid arthritis (RA) in Alberta using administrative health data. Methods We identified RA cases in patients 16 years and older by applying a national case defi
Externí odkaz:
https://doaj.org/article/c21f588515a4434b9f55ea919f5ae9b5
Autor:
Ankoor Shah, Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein, Paul K Wallace, Gregory D Sempowski, Peter McSweeney, Maureen D Mayes, Leslie Crofford, M E Csuka, Kristine Phillips, Dinesh Khanna, Robert Simms, Karen Ballen, Sharon LeClercq, William St Clair, Andrew B Nixon, Richard Nash, Mark Wener, Richard Brasington, Richard Silver, Linda M Griffith, Daniel E Furst, Ellen Goldmuntz, Keith M Sullivan
Publikováno v:
Rheumatology (Oxford)
Objectives The Scleroderma: Cyclophosphamide or Transplantation (SCOT) trial compared hematopoietic stem cell transplant to CYC treatment in patients with early SSc with progressive skin and lung or kidney involvement. Here we describe lymphocyte phe
Autor:
Joanne Homik, Siobhan O'Donnell, Sharon LeClercq, Jatin N. Patel, Elena Lopatina, Jill Roberts, Steven J. Katz, Tram Pham, Dianne Mosher, Claire E.H. Barber, Deborah A. Marshall, Guanmin Chen, Peter Faris
Publikováno v:
ACR Open Rheumatology
ACR Open Rheumatology, Vol 2, Iss 7, Pp 424-429 (2020)
ACR Open Rheumatology, Vol 2, Iss 7, Pp 424-429 (2020)
Objective The objective of the study was to estimate the incidence and prevalence of rheumatoid arthritis (RA) in Alberta using administrative health data. Methods We identified RA cases in patients 16 years and older by applying a national case defi
Autor:
Kam Shojania, Daniel J. Clauw, Shahin Jamal, Zach Walsh, Yoram Shir, Tara Landry, Peter A. Ste-Marie, Jacob Karsh, Mary Ann Fitzcharles, Jason J. McDougall, Winfried Häuser, Sharon LeClercq
Publikováno v:
Arthritis Care & Research. 68:681-688
Objective To assess the efficacy, tolerability, and safety of cannabinoids (phyto- and syntheto-) in the management of rheumatic diseases. Methods Multiple databases, including Medline, Embase, and CENTRAL, were searched. Randomized controlled trials
Autor:
M. B. Kahaleh, Mark H. Wener, Daniel E. Furst, Chitra Hosing, Ashley Pinckney, Oana Craciunescu, Dinesh Khanna, Beverly Welch, Karen K. Ballen, Shin Mineishi, Richard M. Silver, Jan Storek, Lynette Keyes-Elstein, Stephen J. Forman, Shelly Heimfeld, Robert W. Simms, Julia S. Goldstein, Leslie J. Crofford, Maureen D. Mayes, Jonathan G. Goldin, George E. Georges, E. W. Clair, Kristine Phillips, Peter A. McSweeney, Sharon LeClercq, R. Brasington, Rodney J. Folz, Barry Eggleston, Linda M. Griffith, Sharon Castina, Keith M. Sullivan, Dennis Wallace, Christopher Bredeson, L. Griffing, James R. Seibold, Richard A. Nash, R.T. Domsic, Carolyn A. Keever-Taylor, Suzanne Kafaja, Mary Ellen Csuka, Thomas A. Medsger, Ellen Goldmuntz
Publikováno v:
The New England journal of medicine, vol 378, iss 1
BackgroundDespite current therapies, diffuse cutaneous systemic sclerosis (scleroderma) often has a devastating outcome. We compared myeloablative CD34+ selected autologous hematopoietic stem-cell transplantation with immunosuppression by means of 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68524cdf9cc74da8c759fd8ee93d5833
https://escholarship.org/uc/item/34w896c4
https://escholarship.org/uc/item/34w896c4
Autor:
Sophie Ligier, Elzbieta Kaminska, David Robinson, Jean-Pierre Mathieu, Carter Thorne, Marvin J. Fritzler, Niall Jones, Evelyn Sutton, Janet Markland, Paul R. Fortin, Marie Hudson, Solène Tatibouet, Tamara Grodzicky, Ariel Masetto, Sharon LeClercq, Janet E. Pope, Geneviève Gyger, Peter Docherty, Nader Khalidi, Douglas Smith, Maggie Larché, Hebah Alhajeri, Murray Baron
Publikováno v:
Arthritis Care & Research. 67:582-587
Objective The goal of this study was to determine the sensitivity of the new 2013 classification criteria for systemic sclerosis (SSc; scleroderma) in an independent cohort of SSc subjects and to assess the contribution of individual items of the cri
Autor:
Geneviève Gyger, Ariel Masetto, Elzbieta Kaminska, A.R. Cabral, Murray Baron, Chelsea Bentow, Marvin J. Fritzler, M. Hudson, Marie Hudson, Peter Docherty, May Y. Choi, Michael Mahler, David Robinson, Jean-Pierre Mathieu, Carter Thorne, Tamara Grodzicky, Doug Smith, Maggie Larché, Sophie Ligier, Janet E. Pope, Maysan Abu-Hakima, Nader Khalidi, Janet Markland, Paul R. Fortin, Jay Milo, Sharon LeClercq, T.S. Rodriguez-Reyna, Niall Jones, Mianbo Wang, Marc Baron, Evelyn Sutton
Publikováno v:
Autoimmunity reviews. 17(3)
We studied the clinical correlations and epitopes of autoantibodies directed to a novel autoantigen, Bicaudal D (BICD2), in systemic sclerosis (SSc) and reviewed its relationship to centromere protein A (CENP-A). 451 SSc sera were tested for anti-BIC
Publikováno v:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 189(17)
Systemic sclerosis is an uncommon disease (12 new cases per 1 000 000 per year in North America).[1][1] Treatment to date has been mostly symptomatic and supportive. Recently, high-dose immunosuppressive chemo/radiotherapy with autologous hematopoiet
Autor:
Joel David, Milli Gupta, Yasmin Nasser, Sharon LeClercq, Christopher N. Andrews, Matthew Woo, Dorothy Y. Li, Andrew W. Liu, Michelle Buresi, Michael Curley, Jan Storek, Kareem Jamani
Publikováno v:
Gastroenterology. 156:S-1003
Publikováno v:
Scandinavian Journal of Rheumatology. 42:421-424
Autoimmune diseases that are refractory to conventional immunosuppressive therapy may respond to high-dose immunosuppressive therapy with autologous haematopoietic cell transplantation (autoHCT) (1...